T1	Age 2 13	64-year-old
T2	Sex 14 17	man
T3	Clinical_event 22 30	admitted
E1	Clinical_event:T3 
T4	Nonbiological_location 38 68	Department of Gastroenterology
T5	Nonbiological_location 76 150	Affiliated Hospital of Qingdao University Medical College (Qingdao, China)
R1	MODIFY Arg1:T4 Arg2:T5	
R2	MODIFY Arg1:T5 Arg2:E1	
T6	Sign_symptom 169 174	pains
E2	Sign_symptom:T6 
T7	Biological_structure 158 168	epigastric
R3	MODIFY Arg1:T7 Arg2:E2	
T8	Diagnostic_procedure 176 196	Physical examination
E3	Diagnostic_procedure:T8 
T9	Sign_symptom 218 222	mass
E4	Sign_symptom:T9 
A1	POLARITY E4 NEG
T10	Sign_symptom 224 239	lymphadenopathy
E5	Sign_symptom:T10 
A2	POLARITY E5 NEG
T11	Sign_symptom 244 256	organomegaly
E6	Sign_symptom:T11 
A3	POLARITY E6 NEG
T12	Diagnostic_procedure 261 270	endoscopy
E7	Diagnostic_procedure:T12 
T13	Sign_symptom 291 298	lesions
E8	Sign_symptom:T13 
T14	Detailed_description 272 279	several
T15	Biological_structure 280 290	submucosal
R4	MODIFY Arg1:T15 Arg2:E8	
R5	MODIFY Arg1:T14 Arg2:E8	
T16	Biological_structure 322 336	gastric antrum
T17	Biological_structure 345 358	duodenal bulb
R6	MODIFY Arg1:T16 Arg2:E8	
R7	MODIFY Arg1:T17 Arg2:E8	
T18	Diagnostic_procedure 368 394	Endoscopic ultrasonography
E9	Diagnostic_procedure:T18 
T19	Diagnostic_procedure 396 399	EUS
E10	Diagnostic_procedure:T19 
R8	IDENTICAL Arg1:E10 Arg2:E9	
T20	Detailed_description 402 420	OLYMPUS EUS EU-ME2
T21	Detailed_description 422 442	Miniprobe sonography
R9	MODIFY Arg1:T20 Arg2:E9	
R10	MODIFY Arg1:T21 Arg2:E9	
T22	Sign_symptom 466 473	lesions
E11	Sign_symptom:T22 
T23	Distance 479 492	almost 0.5-cm
T24	Detailed_description 507 517	hypoechoic
T25	Sign_symptom 518 527	neoplasms
E12	Sign_symptom:T25 
R11	MODIFY Arg1:T24 Arg2:E12	
R12	MODIFY Arg1:T23 Arg2:E12	
T26	Biological_structure 549 564	submucous layer
R13	MODIFY Arg1:T26 Arg2:E12	
T27	Disease_disorder 613 634	neuroendocrine tumors
E13	Disease_disorder:T27 
T28	Biological_structure 603 612	digestive
R14	MODIFY Arg1:T28 Arg2:E13	
T29	Diagnostic_procedure 636 655	Computed tomography
E14	Diagnostic_procedure:T29 
T30	Sign_symptom 665 685	enlarged lymph nodes
E15	Sign_symptom:T30 
T31	Biological_structure 707 718	mediastinal
T32	Biological_structure 720 735	retroperitoneal
T33	Biological_structure 737 747	mesenteric
T34	Biological_structure 753 761	inguinal
R15	MODIFY Arg1:T31 Arg2:E15	
R16	MODIFY Arg1:T32 Arg2:E15	
R17	MODIFY Arg1:T33 Arg2:E15	
R18	MODIFY Arg1:T34 Arg2:E15	
T35	Sign_symptom 781 788	nodules
E16	Sign_symptom:T35 
T36	Detailed_description 767 780	intracavitary
R19	MODIFY Arg1:T36 Arg2:E16	
T37	Biological_structure 796 804	duodenum
R20	MODIFY Arg1:T37 Arg2:E16	
A4	POLARITY E13 MAYBE_POS
T38	Diagnostic_procedure 868 871	EUS
E17	Diagnostic_procedure:T38 
T39	Diagnostic_procedure 876 882	biopsy
E18	Diagnostic_procedure:T39 
T40	Diagnostic_procedure 901 910	endoscopy
E19	Diagnostic_procedure:T40 
T41	Biological_structure 946 960	terminal ileum
T42	Sign_symptom 923 938	columnar uplift
E20	Sign_symptom:T42 
T43	Area 914 922	2 × 1-cm
R22	MODIFY Arg1:T43 Arg2:E20	
T44	Sign_symptom 985 992	lesions
E21	Sign_symptom:T44 
T45	Biological_structure 1000 1006	rectum
R23	MODIFY Arg1:T45 Arg2:E21	
T46	Biological_structure 974 984	submucosal
T47	Detailed_description 965 973	multiple
R24	MODIFY Arg1:T46 Arg2:E21	
R25	MODIFY Arg1:T47 Arg2:E21	
T49	Sign_symptom 1054 1061	lesions
E23	Sign_symptom:T49 
T50	Biological_structure 1069 1083	terminal ileum
R26	MODIFY Arg1:T50 Arg2:E23	
R27	MODIFY Arg1:T41 Arg2:E20	
T48	Diagnostic_procedure 1032 1035	EUS
E22	Diagnostic_procedure:T48 
R21	SUB_PROCEDURE Arg1:E19 Arg2:E17	
T51	Area 1095 1107	1.6 × 1.2 cm
R28	MODIFY Arg1:T51 Arg2:E23	
T52	Sign_symptom 1116 1123	lesions
E24	Sign_symptom:T52 
T53	Biological_structure 1131 1137	rectum
R29	MODIFY Arg1:T53 Arg2:E24	
T54	Area 1156 1168	0.6 × 1.0 cm
R30	MODIFY Arg1:T54 Arg2:E24	
T55	Detailed_description 1184 1208	homogeneously hypoechoic
T56	Detailed_description 1213 1256	originated from the muscularis mucosa layer
R31	MODIFY Arg1:T55 Arg2:E24	
R32	MODIFY Arg1:T56 Arg2:E24	
T57	Diagnostic_procedure 1258 1282	Pathological examination
E25	Diagnostic_procedure:T57 
T58	Sign_symptom 1318 1325	lesions
E26	Sign_symptom:T58 
T59	Biological_structure 1333 1339	rectum
R33	MODIFY Arg1:T59 Arg2:E26	
T60	Detailed_description 1355 1381	lymphomatous proliferation
R34	MODIFY Arg1:T60 Arg2:E26	
T61	Detailed_description 1386 1404	dense infiltration
R35	MODIFY Arg1:T61 Arg2:E26	
T62	Biological_structure 1408 1471	monomorphic, small cleaved cells with irregularly shaped nuclei
R36	MODIFY Arg1:T62 Arg2:T61	
T63	Diagnostic_procedure 1484 1512	immunohistochemical analysis
E27	Diagnostic_procedure:T63 
T64	Diagnostic_procedure 1542 1551	cyclin D1
E28	Diagnostic_procedure:T64 
T65	Diagnostic_procedure 1553 1557	CD20
E29	Diagnostic_procedure:T65 
T66	Diagnostic_procedure 1559 1563	CD21
E30	Diagnostic_procedure:T66 
T67	Diagnostic_procedure 1565 1571	SOX-11
E31	Diagnostic_procedure:T67 
T68	Diagnostic_procedure 1577 1582	Bcl-2
E32	Diagnostic_procedure:T68 
T69	Diagnostic_procedure 1601 1604	CD3
E33	Diagnostic_procedure:T69 
T70	Diagnostic_procedure 1609 1613	CD10
E34	Diagnostic_procedure:T70 
T71	Lab_value 1529 1537	positive
T72	Lab_value 1588 1596	negative
T73	Disease_disorder 1658 1661	MCL
E35	Disease_disorder:T73 
#1	AnnotatorNotes E35	Mantle cell lymphoma
R37	MODIFY Arg1:T71 Arg2:E28	
R38	MODIFY Arg1:T71 Arg2:E29	
R39	MODIFY Arg1:T71 Arg2:E30	
R40	MODIFY Arg1:T71 Arg2:E31	
R41	MODIFY Arg1:T71 Arg2:E32	
R42	MODIFY Arg1:T72 Arg2:E33	
R43	MODIFY Arg1:T72 Arg2:E34	
R44	SUB_PROCEDURE Arg1:E28 Arg2:E27	
R45	SUB_PROCEDURE Arg1:E29 Arg2:E27	
R46	SUB_PROCEDURE Arg1:E30 Arg2:E27	
R47	SUB_PROCEDURE Arg1:E31 Arg2:E27	
R48	SUB_PROCEDURE Arg1:E32 Arg2:E27	
R49	SUB_PROCEDURE Arg1:E33 Arg2:E27	
R50	SUB_PROCEDURE Arg1:E34 Arg2:E27	
T74	Diagnostic_procedure 1663 1677	Ki-67 staining
E36	Diagnostic_procedure:T74 
T75	Lab_value 1689 1715	proliferative index of 30%
R51	MODIFY Arg1:T75 Arg2:E36	
T76	Disease_disorder 1778 1781	MCL
E37	Disease_disorder:T76 
T77	Lab_value 1759 1777	Ann Arbor stage IV
R52	MODIFY Arg1:T77 Arg2:E37	
T78	Medication 1838 1850	chemotherapy
E38	Medication:T78 
T79	Medication 1856 1865	rituximab
E39	Medication:T79 
T80	Medication 1867 1883	cyclophosphamide
E40	Medication:T80 
T81	Medication 1885 1896	doxorubicin
E41	Medication:T81 
T82	Medication 1898 1909	vincristine
E42	Medication:T82 
T83	Medication 1915 1925	prednisone
E43	Medication:T83 
T84	Medication 1927 1941	R-CHOP regimen
E44	Medication:T84 
R53	SUB_PROCEDURE Arg1:E39 Arg2:E38	
R54	SUB_PROCEDURE Arg1:E39 Arg2:E44	
R55	SUB_PROCEDURE Arg1:E40 Arg2:E38	
R56	SUB_PROCEDURE Arg1:E41 Arg2:E38	
R57	SUB_PROCEDURE Arg1:E42 Arg2:E38	
R58	SUB_PROCEDURE Arg1:E43 Arg2:E38	
R59	SUB_PROCEDURE Arg1:E40 Arg2:E44	
R60	SUB_PROCEDURE Arg1:E41 Arg2:E44	
R61	SUB_PROCEDURE Arg1:E42 Arg2:E44	
R62	SUB_PROCEDURE Arg1:E43 Arg2:E44	
T85	Sign_symptom 1968 1977	remission
E45	Sign_symptom:T85 
*	OVERLAP E5 E6 E7 E8 E4 E3 E9 E11 E12 E13 E14 E15 E16
R63	BEFORE Arg1:E2 Arg2:E3	
R64	BEFORE Arg1:E16 Arg2:E17	
T86	Detailed_description 861 867	repeat
R65	MODIFY Arg1:T86 Arg2:E17	
*	OVERLAP E17 E18 E20 E21 E22 E23 E24 E25 E26 E27 E35 E36 E37
R66	BEFORE Arg1:E37 Arg2:E38	
R67	BEFORE Arg1:E38 Arg2:E45	
